About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Amhr2
anti-Mullerian hormone type 2 receptor
MGI:105062
163 phenotypes from multigenic genotypes
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Amhtm1Bhr/Amh+
Amhr2tm1Bhr/Amhr2tm1Bhr
involves: 129S7/SvEvBrd * C57BL/6 		increased testis tumor incidence J:36027
male pseudohermaphroditism J:36027
secondary sex reversal J:36027
Amhtm1Bhr/Amhtm1Bhr
Amhr2tm1Bhr/Amhr2tm1Bhr
Not Specified 		male infertility J:36027
male pseudohermaphroditism J:36027
normal reproductive system phenotype J:36027
secondary sex reversal J:36027
Amhr2tm1Bhr/Amhr2tm1Bhr
Inhatm1Bay/Inha+
involves: 129S7/SvEvBrd * C57BL/6 		increased testis tumor incidence J:36027
male pseudohermaphroditism J:36027
secondary sex reversal J:36027
Amhr2tm1Bhr/Amhr2tm1Bhr
Inhatm1Bay/Inhatm1Bay
involves: 129S7/SvEvBrd 		dilated uterus J:36027
increased granulosa cell tumor incidence J:36027
increased Leydig cell tumor incidence J:36027
increased testis tumor incidence J:36027
increased tumor incidence J:36027
male pseudohermaphroditism J:36027
secondary sex reversal J:36027
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129S/SvEv * C57BL/6 		early reproductive senescence J:128934
hemoperitoneum J:128934
increased ovarian carcinoma incidence J:128934
increased ovary tumor incidence J:128934
increased testis tumor incidence J:128934
male infertility J:128934
Amhr2tm3(cre)Bhr/Amhr2+
KitW-v/KitW-v
Trp53tm1Brn/Trp53tm1Brn
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J * FVB/N 		increased granulosa cell tumor incidence J:236161
increased ovary adenoma incidence J:236161
increased ovary tumor incidence J:236161
Amhr2tm3(cre)Bhr/Amhr2+
Nr5a1tm1Klp/Nr5a1tm2Klp
involves: 129P2/OlaHsd * 129S7/SvEvBrd 		abnormal endometrial gland development J:145805
abnormal endometrial gland morphology J:145805
abnormal estrous cycle J:145805
abnormal ovarian follicle number J:91352, J:145805
abnormal ovary physiology J:145805
abnormal ovulation J:91352
abnormal seminiferous tubule morphology J:91352
abnormal testis cord formation J:91352
abnormal testis development J:91352
abnormal uterus morphology J:145805
absent corpus luteum J:91352, J:145805
absent estrous cycle J:145805
absent sexual maturation J:91352
arrest of spermatogenesis J:91352
cryptorchism J:91352
decreased circulating estradiol level J:145805
decreased circulating testosterone level J:91352
decreased endometrial gland number J:145805
decreased granulosa cell proliferation J:145805
decreased ovary weight J:145805
decreased primary ovarian follicle number J:145805
decreased primordial ovarian follicle number J:145805
decreased secondary ovarian follicle number J:145805
decreased superovulation rate J:145805
decreased tertiary ovarian follicle number J:145805
decreased uterus weight J:145805
female infertility J:91352, J:145805
impaired ovarian folliculogenesis J:145805
increased circulating follicle stimulating hormone level J:145805
internal male genitalia hypoplasia J:91352
male infertility J:91352
ovarian follicular cyst J:91352
ovary hemorrhage J:91352
ovary hypoplasia J:91352, J:145805
prolonged estrous cycle J:145805
short estrus J:145805
small adrenal glands J:91352
small testis J:91352
testis hypoplasia J:91352
thin myometrium J:145805
Amhr2tm3(cre)Bhr/Amhr2+
Wnt4tm1Amc/Wnt4tm1.1Bhr
involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6J 		normal reproductive system phenotype J:171430
Amhr2tm3(cre)Bhr/Amhr2+
Fsttm1Zuk/Fsttm2Zuk
involves: 129S/SvEv * C57BL/6J 		abnormal ovary morphology J:89081
decreased circulating testosterone level J:89081
decreased corpora lutea number J:89081
decreased litter size J:89081
decreased superovulation rate J:89081
decreased tertiary ovarian follicle number J:89081
female infertility J:89081
normal homeostasis/metabolism phenotype J:89081
impaired fertilization J:89081
increased circulating follicle stimulating hormone level J:89081
increased circulating luteinizing hormone level J:89081
ovary cyst J:89081
ovary hemorrhage J:89081
reduced female fertility J:89081
normal reproductive system phenotype J:89081
Amhr2tm3(cre)Bhr/Amhr2+
Smad3tm1Par/Smad3tm1Zuk
involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 		normal reproductive system phenotype J:142827
Amhr2tm3(cre)Bhr/Amhr2+
Smad2tm1Cxd/Smad2tm1.1Mwst
involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 		normal reproductive system phenotype J:142827
Amhr2tm3(cre)Bhr/Amhr2+
Smad2tm1Cxd/Smad2tm1.1Mwst
Smad3tm1Par/Smad3tm1Zuk
involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 		abnormal cumulus expansion J:142827
abnormal ovarian follicle morphology J:142827
decreased litter size J:142827
decreased oocyte number J:142827
decreased tertiary ovarian follicle number J:142827
increased atretic ovarian follicle number J:142827
increased circulating follicle stimulating hormone level J:142827
increased circulating luteinizing hormone level J:142827
premature ovarian failure J:142827
reduced female fertility J:142827
Amhr2tm3(cre)Bhr/Amhr2+
Ctnnb1tm1Mmt/Ctnnb1+
involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6 		increased granulosa cell tumor incidence J:186144
increased testis tumor incidence J:186144
male infertility J:186144
seminiferous tubule degeneration J:186144
testicular atrophy J:186144
Amhr2tm3(cre)Bhr/Amhr2+
Ctnnb1tm1Mmt/Ctnnb1+
Ptentm1Hwu/Ptentm1Hwu
involves: 129S4/SvJae * 129S7/SvEvBrd * 129X1/SvJ 		anemia J:142150
decreased hematocrit J:142150
extramedullary hematopoiesis J:142150
increased granulosa cell tumor incidence J:149060
increased metastatic potential J:142150, J:149060
increased ovary tumor incidence J:142150
increased testis tumor incidence J:149060
premature death J:142150
pulmonary embolism J:142150
seminiferous tubule degeneration J:149060
Amhr2tm3(cre)Bhr/Amhr2+
Ctnnb1tm1Mmt/Ctnnb1+
Ptentm1Hwu/Ptentm1Hwu
involves: 129S4/SvJae * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6 		increased granulosa cell tumor incidence J:186144
increased testis tumor incidence J:186144
Amhr2tm3(cre)Bhr/Amhr2+
Inhbatm1Zuk/Inhbatm3Zuk
involves: 129S7/SvEvBrd * C57BL/6J 		decreased litter size J:125354
increased corpora lutea number J:125354
polyovular ovarian follicle J:125354
reduced female fertility J:125354
Amhr2tm3(cre)Bhr/Amhr2+
Ctnnb1tm2Kem/Ctnnb1tm2.1Kem
involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ 		abnormal Mullerian duct morphology J:171430
abnormal sex determination J:171430
failure of Mullerian duct regression J:171430
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2.1Rob
Smad5tm1Huy/Smad5tm1Huy
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 		early reproductive senescence J:128934
hemoperitoneum J:128934
increased ovarian carcinoma incidence J:128934
increased ovary tumor incidence J:128934
increased testis tumor incidence J:128934
male infertility J:128934
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2.1Rob
Smad5tm1Huy/Smad5tm1Huy
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J 		increased granulosa cell tumor incidence J:157310
premature death J:157310
suppressed circulating follicle stimulating hormone level J:157310
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2Rob
Smad5tm1Huy/Smad5tm1Huy
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J 		increased granulosa cell tumor incidence J:157310
premature death J:157310
suppressed circulating follicle stimulating hormone level J:157310
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2Rob
Smad5tm1Huy/Smad5tm1Zuk
involves: 129P2/OlaHsd * 129S/SvEv * 129S7/SvEvBrd * C57BL/6 		early reproductive senescence J:128934
hemoperitoneum J:128934
increased ovarian carcinoma incidence J:128934
increased ovary tumor incidence J:128934
increased testis tumor incidence J:128934
male infertility J:128934
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2Rob
Smad5tm1Huy/Smad5tm1Zuk
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J 		increased granulosa cell tumor incidence J:157310
premature death J:157310
suppressed circulating follicle stimulating hormone level J:157310
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2Rob
Smad5tm1Huy/Smad5tm1Zuk
Smad9tm1Jfm/Smad9tm1Jfm
involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 		early reproductive senescence J:128934
hemoperitoneum J:128934
increased ovarian carcinoma incidence J:128934
increased ovary tumor incidence J:128934
Amhr2tm3(cre)Bhr/Amhr2+
Ptentm1Hwu/Ptentm1Hwu
involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6 		abnormal endometrium morphology J:170203
abnormal maternal decidual layer morphology J:170203
abnormal myometrium morphology J:170203
abnormal placenta labyrinth morphology J:170203
abnormal placenta vasculature J:170203
abnormal trophoblast layer morphology J:170203
decreased litter size J:170203
decreased uterine NK cell number J:170203
endometrium fibrosis J:170203
endometrium hyperplasia J:170203
reduced female fertility J:170203
normal reproductive system phenotype J:187754
uterus hyperplasia J:170203
Amhr2tm3(cre)Bhr/Amhr2+
Bmpr1atm1Bhr/Bmpr1atm2.1Bhr
involves: 129S7/SvEvBrd * C57BL/6 		male pseudohermaphroditism J:89999
secondary sex reversal J:89999
Amhr2tm3(cre)Bhr/Amhr2+
Stk11tm1Rdp/Stk11tm1Rdp
involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 		abnormal seminiferous tubule epithelium morphology J:187754
abnormal seminiferous tubule morphology J:187754
abnormal Sertoli cell morphology J:187754
abnormal spermatogenesis J:187754
abnormal testis morphology J:187754
decreased male germ cell number J:187754
decreased testis weight J:187754
increased Sertoli cell proliferation J:187754
normal neoplasm J:187754
small testis J:187754
Amhr2tm3(cre)Bhr/Amhr2+
Artm1Chc/Y
involves: 129S/SvEv * C57BL/6 		abnormal meiosis J:118270
abnormal seminiferous tubule morphology J:118270
arrest of male meiosis J:118270
arrest of spermatogenesis J:118270
azoospermia J:118270
decreased circulating testosterone level J:118270
male infertility J:118270
small seminiferous tubules J:118270
small testis J:118270
Amhr2tm3(cre)Bhr/Amhr2+
Tsc1tm1Djk/Tsc1tm1Djk
involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6 		abnormal myometrium morphology J:181774
abnormal oocyte morphology J:181774
abnormal ovary physiology J:181774
abnormal oviduct morphology J:181774
abnormal preimplantation embryo development J:181774
abnormal seminiferous tubule epithelium morphology J:187754
abnormal seminiferous tubule morphology J:187754
abnormal Sertoli cell morphology J:187754
abnormal spermatogenesis J:187754
abnormal testis morphology J:187754
decreased male germ cell number J:187754
decreased primordial ovarian follicle number J:181774
decreased testis weight J:187754
dilated oviduct J:181774
endometrium hyperplasia J:181774
failure of embryo implantation J:181774
female infertility J:181774
impaired ovarian folliculogenesis J:181774
increased atretic ovarian follicle number J:181774
increased Sertoli cell proliferation J:187754
normal neoplasm J:181774, J:187754
oocyte degeneration J:181774
premature ovarian failure J:181774
prolonged estrus J:181774
normal reproductive system phenotype J:181774
short diestrus J:181774
small testis J:187754
Amhr2tm3(cre)Bhr/Amhr2+
Trp53tm2Tyj/Trp53+
involves: 129S4/SvJae * 129S7/SvEvBrd 		normal neoplasm J:222579
Amhr2tm3(cre)Bhr/Amhr2+
Nr2f2tm2.1Tsa/Nr2f2tm2.1Tsa
involves: 129S7/SvEvBrd 		abnormal maternal decidual layer morphology J:120852
abnormal myometrium morphology J:120852
abnormal placenta development J:120852
abnormal placental labyrinth vasculature morphology J:120852
abnormal uterine environment J:120852
absent placental labyrinth J:120852
decreased spongiotrophoblast cell number J:120852
edema J:120852
embryonic lethality, incomplete penetrance J:120852
hemorrhage J:120852
impaired embryo implantation J:120852
increased miscarriage rate J:120852
increased trophoblast giant cell number J:120852
reduced female fertility J:120852
short uterine horn J:120852
vaginal hemorrhage J:120852
Amhr2tm3(cre)Bhr/Amhr2+
Smad4tm1Rob/Smad4tm1.1Rob
involves: 129S/SvEv * C57BL/6J 		abnormal cumulus expansion J:108954
abnormal granulosa cell morphology J:108954
abnormal ovarian follicle morphology J:108954
abnormal ovarian folliculogenesis J:108954
abnormal secondary ovarian follicle morphology J:108954
absent cumulus expansion J:108954
decreased litter size J:108954
decreased oocyte number J:108954
decreased ovulation rate J:108954
decreased tertiary ovarian follicle number J:108954
increased circulating progesterone level J:108954
increased secondary ovarian follicle number J:108954
infertility J:108954
Amhr2tm3(cre)Bhr/Amhr2+
Tsc2tm1.1Mjg/Tsc2tm1.1Mjg
involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6 		abnormal seminiferous tubule epithelium morphology J:187754
abnormal seminiferous tubule morphology J:187754
abnormal Sertoli cell morphology J:187754
abnormal spermatogenesis J:187754
abnormal testis morphology J:187754
decreased male germ cell number J:187754
decreased testis weight J:187754
increased Sertoli cell proliferation J:187754
normal neoplasm J:187754
small testis J:187754
Amhr2tm3(cre)Bhr/Amhr2+
Ptprvtm1Kry/Ptprvtm1Kry
involves: 129S/SvEv 		normal reproductive system phenotype J:170888
Amhr2tm3(cre)Bhr/Amhr2+
Wnt4tm1.1Boer/Wnt4tm1.2Boer
involves: 129S1/Sv * 129S4/SvJae * 129S7/SvEvBrd * 129X1/SvJ 		abnormal kidney development J:162337
abnormal ovary development J:162337
decreased litter size J:162337
decreased mature ovarian follicle number J:162337
decreased ovary weight J:162337
decreased renal glomerulus number J:162337
disheveled coat J:162337
postnatal growth retardation J:162337
premature death J:162337
Ctnnb1tm1Mmt/Ctnnb1+
Krastm4Tyj/Kras+
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129S4/SvJae * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6 		increased granulosa cell tumor incidence J:186144
increased testis tumor incidence J:186144
seminiferous tubule degeneration J:186144
Dicer1tm1Bdh/Dicer1tm1Bdh
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129 		abnormal oviduct morphology J:142113
abnormal oviduct transport J:142113
abnormal pregnancy J:142113
abnormal uterus morphology J:142113
decreased circulating progesterone level J:142113
decreased endometrial gland number J:142113
decreased ovary weight J:142113
decreased ovulation rate J:142113
decreased superovulation rate J:142113
decreased uterus weight J:142113
failure of embryo implantation J:142113
female infertility J:142113
normal homeostasis/metabolism phenotype J:142113
normal reproductive system phenotype J:142113
short oviduct J:142113
short uterine horn J:142113
small uterus J:142113
thin myometrium J:142113
Dicer1tm1Tara/Dicer1tm1Tara
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129P2/OlaHsd * 129S7/SvEvBrd 		normal neoplasm J:222579
Dicer1tm1Tara/Dicer1tm1Tara
Ptentm1Hwu/Ptentm1Hwu
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd 		abnormal oviduct morphology J:182161
ascites J:182161
increased carcinoma incidence J:182161
increased metastatic potential J:182161
increased ovarian carcinoma incidence J:182161
premature death J:182161
Dicer1tm1Tara/Dicer1tm1Tara
Ptentm1Hwu/Ptentm1Hwu
Trp53tm2Tyj/Trp53+
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd 		ascites J:222579
increased carcinoma incidence J:222579
increased metastatic potential J:222579
increased ovarian carcinoma incidence J:222579
premature death J:222579
Dicer1tm1Tara/Dicer1tm1Tara
Trp53tm2Tyj/Trp53+
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd 		normal neoplasm J:222579
Foxo1tm1Rdp/Foxo1tm1.1Rdp
Foxo3tm1Rdp/Foxo3tm1.1Rdp
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129S6/SvEvTac * 129S7/SvEvBrd 		abnormal circulating hormone level J:232961
abnormal ovarian follicle morphology J:232961
decreased circulating luteinizing hormone level J:232961
increased circulating estradiol level J:232961
increased granulosa cell tumor incidence J:232961
ovary cyst J:232961
suppressed circulating follicle stimulating hormone level J:232961
Gata4tm1.1Sad/Gata4tm1.1Sad
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6J 		abnormal ovary physiology J:173711
abnormal seminiferous tubule epithelium morphology J:169018
abnormal Sertoli cell barrier function J:169018
abnormal Sertoli cell morphology J:169018
abnormal spermatid morphology J:169018
abnormal spermatogenesis J:169018
asthenozoospermia J:169018
decreased circulating anti-Mullerian hormone level J:173711
decreased litter size J:173711
decreased male germ cell number J:169018
decreased sperm progressive motility J:169018
decreased superovulation rate J:173711
decreased testis weight J:169018
failure of superovulation J:173711
female infertility J:173711
normal homeostasis/metabolism phenotype J:169018
increased male germ cell apoptosis J:169018
multinucleated giant male germ cells J:169018
oligozoospermia J:169018
ovarian follicular cyst J:173711
ovary cyst J:173711
reduced female fertility J:173711
reduced male fertility J:169018
normal reproductive system phenotype J:169018, J:173711
seminiferous tubule degeneration J:169018
small ovary J:173711
small testis J:169018
testicular atrophy J:169018
Inhbatm1Zuk/Inhbatm3Zuk
Inhbbtm1Jae/Inhbbtm1Jae
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J 		abnormal ovarian follicle morphology J:125354
abnormal tertiary ovarian follicle morphology J:125354
absent oocytes J:125354
female infertility J:125354
increased corpora lutea number J:125354
increased follicle stimulating hormone level J:125354
increased ovary weight J:125354
ovarian follicular cyst J:125354
Kat8tm1Thl/Kat8tm1Thl
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6 		normal reproductive system phenotype J:242000
Kmt2btm1Afst/Kmt2btm1.1Afst
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 		abnormal DNA methylation J:166778
abnormal ovarian follicle number J:166778
decreased primary ovarian follicle number J:166778
decreased primordial ovarian follicle number J:166778
decreased secondary ovarian follicle number J:166778
increased atretic ovarian follicle number J:166778
increased circulating follicle stimulating hormone level J:166778
reduced female fertility J:166778
Ptentm1Hwu/Ptentm1Hwu
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129S4/SvJae * 129S7/SvEvBrd 		abnormal pregnancy J:142150
decreased litter size J:142150
increased granulosa cell tumor incidence J:142150, J:222579
increased metastatic potential J:142150
normal reproductive system phenotype J:142150
Ptentm1Hwu/Ptentm1Hwu
Trp53tm2Tyj/Trp53+
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd 		ascites J:222579
increased granulosa cell tumor incidence J:222579
increased metastatic potential J:222579
increased ovarian carcinoma incidence J:222579
premature death J:222579
Tspotm1.1Wbd/Tspotm1.1Wbd
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6 		normal reproductive system phenotype J:207708
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory